Physician profile
Lucy Li
NPI 1144938648
$2,916.53
in general payments reported to CMS, 2019-2025
10 companies · $942 in 2025
The $942 reported for 2025 was more than what 84% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $50.47 · 2024: $1,924 · 2025: $942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,916.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,340.28 | 2024-2025 | |
| Janssen Biotech, INC. | $989.07 | 2024-2025 | Tremfya, Stelara |
| Lilly USA, LLC | $278.68 | 2023-2025 | Omvoh |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.44 | 2024 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.97 | 2024 | Cyltezo |
| Organon LLC | $44.58 | 2024 | |
| Sandoz INC. | $39.44 | 2024-2025 | Hyrimoz |
| Aimmune Therapeutics, INC. | $30.77 | 2025 | Vowst |
| Celgene Corporation | $29.25 | 2024 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $21.05 | 2024 | Entyvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucy Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.